SEC Filing Update: #CCCC C4 Therapeutics, Inc. : $4.31

Sector: Healthcare | YTD: 🔼+ 123.32% The SEC disclosed Today (14-AUG-2026) that Lynx1 Capital Management LP has INCREASED #CCCC Shares by 110.51% 🟢 Squadron Master Fund LP also reported an increase in its holdings on the same day. RA CAPITAL MANAGEMENT also reported an increase in its holdings on the same day. * Previous Holdings: 7.33M Shares * Current Holdings: 15.42M Shares * Increase+8.10M * Increased(%)+110.51% * Ownership: 9.99% * Estimated Investment Value: $30.61M https://www.thinksabio.com/reports/isr/CCCC Institutional ownership in #CCCC has been steadily rising over the past 3 quarters in Shares: Q3 2025: 52.54M Q4 2025: 79.83M Q1 2026: 84.49M 📌 Institutional activity in the last 30 days for #CCCC: • Squadron Master Fund LP – Increased holdings by 2,050,000 shares (14-AUG-2026) • RA CAPITAL MANAGEMENT – Increased holdings by 3,383,696 shares (14-AUG-2026) • BLACKROCK INC – Increased holdings by 5,630,380 shares (27-JUL-2026)